Head to Head Contrast: Pro Medicus (OTCMKTS:PMCUF) & LogicMark (NASDAQ:LGMK)

Pro Medicus (OTCMKTS:PMCUFGet Free Report) and LogicMark (NASDAQ:LGMKGet Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares Pro Medicus and LogicMark’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pro Medicus N/A N/A N/A
LogicMark -146.14% -104.48% -79.87%

Institutional & Insider Ownership

10.8% of Pro Medicus shares are held by institutional investors. Comparatively, 7.9% of LogicMark shares are held by institutional investors. 12.4% of LogicMark shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Pro Medicus and LogicMark”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pro Medicus N/A N/A N/A $0.02 8,233.33
LogicMark $9.74 million 0.03 -$14.55 million ($10.71) -0.01

Pro Medicus has higher earnings, but lower revenue than LogicMark. LogicMark is trading at a lower price-to-earnings ratio than Pro Medicus, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Pro Medicus and LogicMark, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro Medicus 0 0 0 0 N/A
LogicMark 0 0 0 0 N/A

Summary

Pro Medicus beats LogicMark on 6 of the 8 factors compared between the two stocks.

About Pro Medicus

(Get Free Report)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

About LogicMark

(Get Free Report)

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.